We are live on ! Find out more
VYNT

Vyant Bio

Delisted

VYNT was delisted on the 12th of May, 2023.

29 hedge funds and large institutions have $3.64M invested in Vyant Bio in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

3.6% less ownership

Funds ownership: 12.99% → 9.38% (-3.6%)

28% less funds holding

Funds holding: 40 → 29 (-11)

84% less capital inflows, than outflows

Capital inflows: $300K | Capital outflows: $1.92M

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 12

Holders
29
Holders Change
-11
Holders Change %
-27.5%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
10
Reduced
6
Closed
12
Calls
$667​K
Puts
–
Net Calls
+$667​K
Net Calls Change
-⁠$105​K

VYNT Hedge Fund Activity: Q1 2016 in Review

29 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio (VYNT) for Q1 2016, worth a combined $3.64M — down 38% from $5.84M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of VYNT and 1 opened new positions — a net loss of 11 holders — while 6 trimmed existing stakes and 10 added.

The largest buyer was Quality Growth Management, adding an estimated $75.2K. The largest seller was Millrace Asset Group, exiting entirely with an estimated $588K sold.

  • 29 institutional investors held Vyant Bio (VYNT) as of Q1 2016, down from 40 in Q4 2015.
  • Funds reported $3.64M of Vyant Bio stock for Q1 2016, down 38% quarter-over-quarter.
  • 1 fund opened new Vyant Bio positions in Q1 2016 and 12 closed out, a net change of -11 holders.
  • The largest Vyant Bio buyer in Q1 2016 was Quality Growth Management, an estimated $75.2K added.
  • The largest Vyant Bio seller in Q1 2016 was Millrace Asset Group, an estimated $588K sold.

Based on aggregated 13F filings for Q1 2016.